
LINC.ST does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for LINC.ST and 80,000+ other tickers.
See exactly how LINC.ST's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for LINC.ST and 80,000+ other tickers.
Linc AB operates as a private equity and venture capital firm, dedicating its investments to the pharmaceutical, life sciences, and med-tech sectors across early, mid, and late venture stages. The firm prioritizes investment opportunities within Nordic companies. Its typical investment amounts range from SEK 25 million to SEK 250 million, frequently beginning with a relatively smaller initial capital injection, with subsequent follow-up investments constituting the majority of its financial commitment. Linc AB's headquarters are located in Stockholm, Sweden.
No recent news available.